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Abstract : We previously showed that chemotherapy-induced dysgeusia was associated with lingual taste recep-
tor gene expression, and monosodium glutamate (MSG) improved dysgeusia by upregulating taste 1 receptor 3 
(T1R3) gene expression. In recent years, decreased taste sensitivity has also been reported in some young people, 
and these are partly due to their disordered eating habits. From these background, we investigated the effects of 
MSG supplementation on taste receptor expression and dietary intake in healthy females. Fifteen young healthy 
volunteers were enrolled for the present crossover study and divided in two groups (dietary supplementation 
with MSG at 2.7 g / day or 0.27 g / day). The relative expression of T1R3, a subunit of both umami and sweet taste 
receptors, in the tongue was assessed by quantitative PCR analysis. Food intake was assessed by food frequency 
questionnaire (FFQg), and body composition was measured using Omron HBF-701. T1R3 expression levels in the 
tongue and taste sensitivity increased significantly in participants who consumed <10 g of MSG daily, whereas 
no alteration was observed in participants who consumed >10 g of MSG daily. Furthermore, protein, fat, and 
carbohydrate (PFC) balance and salt and sugar intake improved by MSG supplementation. In conclusion, MSG 
supplementation increased T1R3 expression in the tongue and improved dietary balance. J. Med. Invest. 68 : 315-
320, August, 2021
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INTRODUCTION
 
Dysgeusia is serious because it lowers quality of life and exac-
erbates pathological conditions, including weight loss and malnu-
trition. Taste sensitivity is an important factor for maintaining 
life as well as for enjoying diet (1). In addition to medication and 
aging, there are several causes of decreased taste sensitivity. 
Cancer therapy, diabetes, infection and inflammation, vitamin 
B12 or zinc deficiencies, or dry months are well-known causes. 
In addition, COVID-19 induces chemosensory loss, such as loss 
of taste and smell. Many cases of dysgeusia caused by COVID-19 
have been reported worldwide (2-6). 
Sense of taste is critical for the identification of healthy nu-
trients and avoiding unhealthy compounds, such as spoiled or 
poisonous food. However, even in young people, taste sensitivity 
is sometimes lowered, without the being person aware of it (7). In 
general, reduced taste sense leads to inadequate dietary intake, 
resulting in malnutrition or overeating, whereas low levels of 
taste sensation are also caused by food habits in healthy subjects 
(8).
The basic taste modalities are sweet, sour, bitter, salty, and 
umami, which are perceived by specific taste receptors in 
the taste buds on the tongue (9). Umami taste was identified 
more than 100 years ago by a Japanese scientist, Dr. Kikunae 
Ikeda ; however, it has been recognized as a fifth distinct taste 
owing to the identification of its receptors in the last two decades 
(10-12). Umami and sweet taste receptors are heterodimeric pro-
teins composed of taste 1 receptor 1 (T1R1) and T1R3 and T1R2 
and T1R3 subunits, respectively (13), whereas bitter taste re-
ceptors are monomers of the 25 types of T2R subunits (14). Pre-
viously, we reported that lingual taste receptor gene expression 
was associated with chemotherapy-induced dysgeusia in patients 
with head and neck cancer (15). T1R3 gene expression decreases 
after chemotherapy, whereas T2R5 gene expression increases, 
which is correlated with decreased taste sense.
Monosodium salt of L-glutamate (MSG) is an umami com-
pound used worldwide as a seasoning and is detected by umami 
taste receptors in the tongue (16). We have recently found that 
stimulation of taste buds with MSG results in upregulation 
of T1R1 and T1R3 expression levels in the tongue of patients 
with head and neck cancer undergoing chemotherapy. Here, we 
analyzed the effect of MSG supplementation in healthy young 
females. MSG was added to rice at each meal three times per 
day for seven days. A mucosal scraping sample was obtained 
from the foliate papillae on the tongue of study subjects to assess 
T1R3 abundance by real-time PCR analysis. In addition, we 
examined the effects of dietary supplementation with MSG on 
daily dietary intake.
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SUBJECTS AND METHODS
Subjects and study design
The study was approved by the Tokushima University Hospi-
tal Committee for Medical Ethics (approval number : 2405), and 
written informed consent was obtained from each patient prior 
to enrollment. The Study design complied with the guidelines 
of Declaration of Helsinki, and all methods were performed 
in accordance with the relevant guidelines and regulations of 
the Institutional Ethics Committee of Tokushima University 
Hospital, Japan. The study was designed as a crossover study. 
Fifteen healthy young participants were enrolled in the study. 
The participants were randomly divided into two groups : one 
group included eight participants who were supplemented with 
2.7 g / day (0.9 g / meal) MSG for the first week. After 2 weeks of 
wash out, they were then supplemented with 0.27 g / day (0.09 
g / meal) MSG for a week. Another group included other seven 
participants who were supplemented with 0.27 g / day MSG for 
the first week and 2.7 g / day for another week. MSG was pro-
vided in the form of seasoning, with a double-blind addition of a 
seasoning containing 0.9 g or 0.09 g of MSG. 
Dietary MSG supplementation
The patients were randomly divided into two groups. One 
group (group A) comprised seven participants (all seven were 
women) and another group (group B) comprised eight partic-
ipants (of which seven were women). MSG powder was added 
directly to rice as a seasoning provided by Marumiya Co. Ltd. 
(Tokyo, Japan) (Table 1), and the powder was sprinkled over rice. 
The powder contained 0.09 g or 0.9 g of MSG for consumption 
three times per day for seven days.
RT-PCR analysis 
The surface of the foliate papillae on the tongue of patients was 
scraped with a small spatula after local anesthesia with 4% lido-
caine to collect a sample of the lingual mucosa (24). Scraping was 
performed immediately before and one week after the first and 
second doses of chemotherapy. All tissue scrapings were immedi-
ately mixed with RNAlater solution (Ambion, Austin, TX, USA), 
and RNA was extracted using an RNAqueous phenol-free RNA 
isolation kit (Ambion) and amplified using the CellAmp Whole 
Transcriptome Amplification Kit Version 2 (Takara Bio, Shiga, 
Japan). Total RNA (1 µg) was reverse-transcribed in a final vol-
ume of 20 µL using the Primescript RT Reagent Kit (Takara Bio). 
The resulting cDNA (50 ng) was subjected to real-time PCR using 
specific primers in a final volume of 10 µL using StepOnePlus 
Real-Time PCR System (Life Technologies, Waltham, MA, 
USA). The sequences of the primer sets used (forward and re-
verse, respectively) were 5′-TTCCCCCAGTACGTGAAGAC-3′ 
and 5′-CAGAGAACGTCTGGTGGTGA-3′ for human T1R3 
and 5 ′-GAAATCCCATCACCATCTTCCAGG-3 ′ and 5 ′-
GAGCCCCAGCCTTCTCCATG-3 ′ for human glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) (Invitrogen, 
Waltham, MA, USA). PCR products were quantified by fit-point 
analysis, and the expression of T1R3 was normalized to that of 
GAPDH.
Daily dietary intake
Dietary intake was calculated by a registered dietician by 
assessing food frequency questionnaire (FFQg) version 4.0. 
Average energy and all nutrients intake over seven days was 
compared between the weeks before and after the first and sec-
ond doses of supplementation. To assess glutamate intake, we 
also assessment dietary intake by 24-hour diet recall assessment 
and calculated amount of glutamate using Japan Food Standard 
Component Table 2015, An Amino Acid Component.
Body composition
Body weight and body composition were assessed using a 
TANITA dual-frequency body composition analyzer (TANITA 
320).
Statistical analysis
Data are presented as mean ± standard deviation. Paired 
t-test was performed after assessing the normality of data. Mul-
tiple comparisons were performed using the Kruskal–Wallis test 
and two-way analysis of variance. If an overall significant differ-
ence was detected, the Tukey–Kramer test was applied to identi-
fy pairs showing significant differences. All statistical analyses 
and graph generation were conducted using JMP (SAS Institute, 
Tokyo, Japan) or PRISM 7 software (GraphPad Software, San 
Diego, CA, USA). Statistical significance was set at p < 0.05.
RESULTS
Participant characteristics
A total of 15 healthy participants [21–26-years-old (23.2 ± 1.6 
years)] with no medication were enrolled in the study (Table 2). 
There were no differences in body composition and energy intake 
between the groups before supplementation. The abundance of 
T1R3 varied from individual to individual and was not associ-
ated with nutritional intake, such as sugar and glutamic acid, 
and dietary intake, such as sugar, confectionery, and favorite 
beverages (data not shown).
Change in food intake and body composition and T1R3 expression 
after MSG supplementation
We compared energy and food intake before and after sup-
plementation with MSG. Intake of 0.27 g / day MSG did not 
change food intake, including energy and salt intake, whereas 
after 2.7 g / day MSG supplementation, energy, salt and sugar 
intake reduced (Table3, Figure1A-C). Intake of snacks were 
decreased after 2.7 g MSG intervention, suggesting that inter-
vention reduced these nutrients such as salt and sugar. Other 
nutrients such as protein and fat were not altered (Table3). Body 
composition, i.e., body fat, lean body fat, and intracellular and 
extracellular body fat did not change throughout the study (data 
not shown). In addition, nausea, vomiting, and diarrhea did not 
occur after supplementation. 
Next, we analyzed lingual T1R3 gene expression before and 
after MSG supplementation. Supplementation with 0.27 g / day 
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Age (year) 23.8 ± 1.5 22.9 ± 1.6 p = 0.3424
Gender (male / female) 0/8 0/7
Anthropometrics
weight (kg) 53.7 ± 6.4 54.1 ± 7.3 p = 0.2261
BMI (kg / m2) 21.4 ± 3.1 21.8 ± 2.8 p = 0.1457
body fat (%) 29.7 ± 7.6 28.9 ± 7.7 p = 0.3164
lean body mass (kg) 36.5 ± 5.9 37.5 ± 9.2 p = 0.3919
Blood pressures (BP, mmHg)
Systolic BP 128.5 ± 10.5 124.5 ± 17.9 p = 0.3862
Diastolic BP 78.5 ± 12.8 80.5 ± 16.9 p = 0.2661
Hypertension ( > 140 / 90 mmHg) 0 0 n.s
Herat Rate 70.2 ± 10.6 71.3 ± 12.2 p = 0.1125
Dietary assessment
Energy intake (kcal / day) 2064.0± ± 239.4 1917.5 ± 251.5 p = 0.2612
protein intake (g / day) 58.0 ± 6.9 60.8 ± 5.1 p = 0.3428
carbohydrate intake (g / day) 224.0 ± 56.5 265.5 ± 48.9 p = 0.2827
sugar intake (g / day) 9.5 ± 4.9 8.9 ± 3.7 p = 0.2812
salt intake (g / day) 8.5 ± 3.9 18.2 ± 4.5 p = 0.6525
Characteristics of participants before the intervention.






Energy intake (kcal / day) 2032.0 ± 246.5 2017.4± ± 257.8 1872.4 ± 210.8*
protein intake (g / day) 59.9 ± 6.3 61.8 ± 4.1 60.8 ± 4.1
carbohydrate intake (g / day) 223.0 ± 54.7 245.5 ± 48.9 245.5 ± 40.1
Fat intake (g / day) 45.6 ± 14.2 43.0 ± 11.2 41.0 ± 11.7
sugar intake (g / day) 10.5 ± 4.9 10.1 ± 3.4 8.6 ± 3.1*
salt intake (g / day) 11.9 ± 3.9 10.2± ± 4.5 8.1 ± 1.8*
Glutamate  (g / day) 15.4 ± 3.9 16.7 ± 3.1 16.3 ± 4.1
*p < 0.05 versus pretreatment
Figure 1.　Change of energy, salt and sugar intake during intervention.
A) Energy intake, B) Salt intake, C) Sugar intake, were investigated before and after 0.27 g / day MSG intervention and before and 
after 0.27 g / day MSG intervention. One-way ANOVA and paired t test were performed. N = 15, each.
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MSG did not change T1R3 gene expression (Figure2A). After 2.7 
g / day MSG supplementation, eight participants (53%) showed 
increased lingual T1R3 gene expression, but it remained un-
changed in other participants (Figure2B-C).
Stratified analysis of T1R3 gene expression after MSG supplementation
Therefore, further analysis was performed to clarify why 
some participants exhibited increased T1R3 gene expression 
but others did not. Comparing the group in which T1R3 gene 
expression increased by supplementation of 2.7 g of MSG and 
the group in which there was no change, there was no significant 
difference in energy intake, but the group with increased T1R3 
gene expression had lower protein intake (43.2 g / day vs. 67.6 
g / day ; p < 0.05), and the average intake of glutamate was also 
less than 10 g per day before intervention (9.6 g / day vs. 21.4 
g / day) (Figure3A-B). In addition, the group with increased T1R3 
expression had higher salt and sugar intake before intervention 
(Figure3C-D) before intervention. In the group with increased 
T1R3 gene expression, such low protein intake and high salt 
and sugar intake improved after MSG addition. That is, protein 
Figure 3.　Comparison of protein, glutamate, salt and sugar intake amount.
A) Protein, B) Glutamate, C) Salt, D) Sugar intake amounts were showed in two group. Changed :  group that T1R3 gene expression was 
increased by 2.7 g / day MSG supplementation ; closed bar (n = 8). Unchanged : group that T1R3 gene expression was unchanged after 2.7 g / day 
MSG supplementation ; opened bar (n = 7). *p < 0.05, unpaired student t-test.
Figure 2.　Lingual T1R3 gene expression during intervention.
A) Lingual T1R3 gene expression before and after 1, 2, 3 and 4 weeks of supplementation with 0.27 g / day MSG intervention. B) Lingual T1R3 
gene expression before and after 1, 2, 3 and 4 weeks of supplementation with 2.7 g / day MSG intervention. N = 15, each. C) Comparison of Lingual 
T1R3 gene expression between T1R3 changed and unchanged groups. One-way ANOVA were performed. Changed ; n = 8, unchanged ; n = 7
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intake increased after the intervention of 2.7 g MSG, salt and 
sugar intake decreased, and was within the generally recom-
mended dietary intake range. There was no clear difference in 
energy intake between the group with increased T1R3 gene and 
the group without change in T1R3 gene after MSG intervention. 




MSG is a sodium salt of glutamic acid (glutamate, Glu). Glu-
tamate is a non-essential amino acid, and is the most abundant 
amino acid found in nature (17). However, MSG is a controver-
sial compound regarding its use in the food industry. In this 
study, we investigated the effect of supplementation with MSG 
on dietary balance and taste receptor T1R3 gene expression 
in healthy females. We focused on the effects of MSG and not 
on those of other umami compounds, such as 5′-ribonucleotides 
guanosine monophosphate and inosine monophosphate, as our 
preliminary work showed that MSG was the only compound that 
increased T1R3 expression in the tongue of mice (unpublished 
data). The human T1R1 / T1R3 heterodimer is activated by glu-
tamate (18). We previously observed that during the first round 
of chemotherapy (cisplatin only or a combination of cisplatin and 
5-fluorouracil) during chemoradiotherapy resulted in a decrease 
in T1R3 expression levels in the lingual mucosa and taste sen-
sitivity in patients with advanced head and neck cancer. These 
effects were attenuated by dietary supplementation with MSG 
during the second round of chemotherapy (unpublished data). 
In addition, we focused on T1R3 because chemotherapy (but not 
radiation therapy) reportedly reduces T1R3 expression in the 
tongue of patients with head and neck cancer without altering 
T1R1 or T1R2 expression (15).
MSG is recognized as the main ingredient of umami taste. 
Recently, the health benefits of umami has received consider-
able attention. The use of umami can help reduce excessive salt 
intake, which contributes to cardiovascular disease. Differences 
in the salt-exposed environment at birth and preference for salty 
taste may affect the sense of taste (19). In addition, Mizuta et 
al. demonstrated that umami taste disorder is a predictor of 
obesity and suggested that umami contributes to meal satisfac-
tion (20). Supplementation of MSG in elderly patients promotes 
gastric acid and bile acid secretion and contributes to increased 
dietary intake and improved nutrient absorption rate, resulting 
in improved nutritional status (21, 22). Oral administration of 
MSG also increased gastrointestinal mRNA and protein levels 
of T1R1 and T1R3 in piglets (23). Although the precise mecha-
nisms of these effects remain unclear, it is likely that the inter-
action of MSG with T1R1 / T1R3 umami receptors in the tongue 
of patients with head and neck cancer activates intracellular 
signals that elicit the expression of T1R3, thereby compensating 
for the inhibitory effect of chemotherapy.
In this study, we aimed to determine whether the increase in 
T1R3 gene expression by MSG supplementation may be depen-
dent on glutamate intake from the original diet. In subjects with 
low glutamate intake and low protein intake, the state of “gluta-
mate undernutrition” suppressed T1R3 gene expression, which 
was considered to be improved by adding 2.7 g of glutamate daily. 
In these subjects, in addition to low protein intake, high salt 
and sugar intake was corrected by supplementation with MSG. 
There is a strong association between sweet and umami tastes, 
and supplementation with MSG may support reduced sugar 
intake (24). Although MSG includes sodium, taste satisfaction 
with MSG may also have contributed to reduced salt intake.
The present study has several limitations. First, taste 
sensation was not assessed using an accurate taste test. Only 
interviews were conducted regarding dysgeusia, and it was 
confirmed that none of the subjects had any subjective ab-
normalities. However, a more accurate taste test, such as the 
whole-mouth gustatory test, is required to be performed because 
sometimes even young healthy subjects present dysgeusia. Sec-
ond, the number of subjects was relatively small and the study 
was designed as a crossover study. Third, only women were 
included this study. Gender differences are also considered to 
be involved in taste and gene expression, but we have not been 
able to examine gender differences in this study. Thus, further 
randomized clinical trials are required to confirm our findings.
In conclusion, this study showed that dietary supplementation 
with MSG improves dietary balance by increasing T1R3 taste 
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